The Kaplan–Meier plotter survival analysis indicated that, despite higher levels of expression of the receptor occurred in the intestinal subtype, high FGFR4 levels are a poor prognostic indicator in patients with diffuse type of GC, but not in patients with intestinal subtype. The gene discussed is FGFR4; the disease is gastric cancer.